Ciproguard 500 mg (Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Ciprofloxacin |
| Company | Guardian healthcare ltd |
Product Title and Categories
- Ciproguard
- Anti-infective Agent
- Antibacterial Medication
- Quinolone Preparations
- Antimicrobial Drugs
Dimensions
Dosage Range
- 100-750 mg twice daily for adults
- 250-500 mg twice daily for urinary tract infections
- 250-500 mg twice daily for respiratory tract infections
- 750 mg twice daily for streptococcus pneumonia infection
- 250 or 500 mg for gonorrhea
- 500-750 mg twice daily for most other infections
- 750 mg twice daily for cystic fibrosis in adults
- 7.5-15 mg/kg/day for adolescents and children
Usability Features
- Adults: Can be administered using a dosage range of 100-750 mg twice daily.
- Urinary Tract Infections: Treatment includes a dosage range of 250-500 mg twice daily.
- Respiratory Tract Infections: Dosage ranges from 250-500 mg twice daily, with the higher end for streptococcus pneumonia infection.
Renal Function Adjustment
Dose adjustment may be necessary for patients with severe renal impairment.
Elderly Dosage
No adjustment of dosage is necessary for elderly patients.
Duration of Treatment
The usual treatment period is 5 to 10 days with Ciprofloxacin tablets.
Extended-release Table
Recommended doses for uncomplicated urinary tract infection (acute cystitis) and IV infusion for various infections.
Administration
- Instruction for the use of Ciprofloxacin IV infusion.
- Steps for IV infusion administration.
Interaction with Other Products
Concurrent administration of Ciproguard should be avoided with certain antacids or products containing calcium, iron or zinc.
Contraindications
Patients with a history of hypersensitivity to Ciprofloxacin or other quinolones.
Side Effects
Gastrointestinal disturbances, disturbances of the central nervous system, hypersensitivity reactions, joint pain, mild photosensitivity, and transient increase in liver enzymes.
Pregnancy & Lactation
Use of Ciprofloxacin during pregnancy and nursing is not recommended due to potential risk.
Precautions & Warnings
Use with caution in patients with suspected or known CNS disorders and certain precautions for concurrent administration with other products.
Special Population Usage
Although effective in clinical trials, Ciproguard is not a first-choice drug in the pediatric population.
Overdose Effects
May lead to seizures, hallucinations, confusion, abdominal discomfort, and renal and hepatic impairment.
Storage Conditions
Keep below 30°C temperature, protected from light and moisture.